AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 26-50/101

Authors: Kollmannsberger, C Gerl, A Schleucher, N Beyer, J Kuczyk, M Rick, O Gasper, J Sosada, M Rie, C Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer, ANTI-CANC D, 11(7), 2000, pp. 535-539

Authors: Hartmann, JT Knop, S Fels, LM van Vangerow, A Stolte, H Kanz, L Bokemeyer, C
Citation: Jt. Hartmann et al., The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors, ANTI-CANC D, 11(1), 2000, pp. 1-6

Authors: Hebart, H Loeffler, J Kanz, L Einsele, H
Citation: H. Hebart et al., Molecular methods in the diagnosis of infections in the immunocompromised host, CURR OPIN I, 13(4), 2000, pp. 355-359

Authors: Bethge, W Guggenberger, D Bamberg, M Kanz, L Bokemeyer, C
Citation: W. Bethge et al., Thyroid toxicity of treatment for Hodgkin's disease, ANN HEMATOL, 79(3), 2000, pp. 114-118

Authors: Kollmannsberger, C Nichols, C Meisner, C Mayer, F Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: An explorative analysis using cart modeling, ANN ONCOL, 11(9), 2000, pp. 1115-1120

Authors: Kollmannsberger, C Nichols, C Bamberg, M Hartmann, JT Schleucher, N Beyer, J Schoffski, P Derigs, G Ruther, U Bohlke, I Schmoll, HJ Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases, ANN ONCOL, 11(5), 2000, pp. 553-559

Authors: Bokemeyer, C Kollmannsberger, C Hartmann, JT Kanz, L
Citation: C. Bokemeyer et al., Follow up after primary treatment: curable diseases treated non-surgically, ANN ONCOL, 11, 2000, pp. 73-78

Authors: Bokemeyer, C Hartmann, JT Mayer, F Bohlke, I Kanz, L von Pawel, J Derigs, G Schroder, M
Citation: C. Bokemeyer et al., UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumors, ONCOLOGY-NY, 14(10), 2000, pp. 63-67

Authors: Gunaydin, I Pereira, PL Daikeler, T Mohren, M Trubenbach, J Schick, F Kanz, L Kotter, I
Citation: I. Gunaydin et al., Magnetic resonance imaging guided corticosteroid injection of the sacroiliac joints in patients with therapy resistant spondyloarthropathy: A pilot study, J RHEUMATOL, 27(2), 2000, pp. 424-428

Authors: Bautz, F Rafii, S Kanz, L Mohle, R
Citation: F. Bautz et al., Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells: Possible role in the hematopoietic microenvironment, EXP HEMATOL, 28(6), 2000, pp. 700-706

Authors: Kratz-Albers, K Scheding, S Mohle, R Buhring, HJ Baum, CM Mc Kearn, JP Buchner, T Kanz, L Brugger, W
Citation: K. Kratz-albers et al., Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin, EXP HEMATOL, 28(3), 2000, pp. 335-346

Authors: Schafer, H Bader, P Kaiserling, E Klingebiel, T Handgretinger, R Kanz, L Einsele, H
Citation: H. Schafer et al., Extramedullary relapses at uncommon sites after allogeneic stem cell transplantation, BONE MAR TR, 26(10), 2000, pp. 1133-1134

Authors: Einsele, H Hebart, H Kauffman-Schneider, C Sinzger, C Jahn, G Bader, P Klingebiel, T Dietz, K Loffler, J Bokemeyer, C Muller, CA Kanz, L
Citation: H. Einsele et al., Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection, BONE MAR TR, 25(7), 2000, pp. 757-763

Authors: Hartmann, JT Fels, LM Franzke, A Knop, S Renn, M Maess, B Panagiotou, P Lampe, H Kanz, L Stolte, H Bokemeyer, C
Citation: Jt. Hartmann et al., Comparative study of the acute nephrotoxicity from standard dose cisplatin+/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide, ANTICANC R, 20(5C), 2000, pp. 3767-3773

Authors: Hartmann, JT Kanz, L Bokemeyer, C
Citation: Jt. Hartmann et al., Phase II study of continuous 120-hour- infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma, ANTICANC R, 20(2B), 2000, pp. 1177-1182

Authors: Hartmann, JT Fels, LM Knop, S Stolte, H Kanz, L Bokemeyer, C
Citation: Jt. Hartmann et al., A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors, INV NEW DR, 18(3), 2000, pp. 281-289

Authors: Braun, N Faul, C Wernet, D Schnaidt, M Stuhler, G Kanz, L Risler, T Einsele, H
Citation: N. Braun et al., Successful transplantation of highly selected CD34+peripheral blood stem cells in a HLA-sensitized patient treated with immunoadsorption onto proteinA, TRANSPLANT, 69(8), 2000, pp. 1742-1744

Authors: Brugger, W Scheding, S Ziegler, B Buhring, HJ Kanz, L
Citation: W. Brugger et al., Ex vivo manipulation of hematopoietic stem and progenitor cells, SEM HEMATOL, 37(1), 2000, pp. 42-49

Authors: Machann, J Pereira, PL Einsele, H Kanz, L Claussen, CD Schick, F
Citation: J. Machann et al., MR Characterization of the hemapoetic bone marrow. Findings in generalizedneoplasia and treatment monitoring, RADIOLOGE, 40(8), 2000, pp. 700-709

Authors: Hebart, H Loffler, J Meisner, C Serey, F Schmidt, D Bohme, A Martin, H Engel, A Bunjes, D Kern, WV Schumacher, U Kanz, L Einsele, H
Citation: H. Hebart et al., Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening, J INFEC DIS, 181(5), 2000, pp. 1713-1719

Authors: Brossart, P Zobywalski, A Grunebach, F Behnke, L Stuhler, G Reichardt, VL Kanz, L Brugger, W
Citation: P. Brossart et al., Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells, CANCER RES, 60(16), 2000, pp. 4485-4492

Authors: Hartmann, JT Nichols, CR Droz, JP Horwich, A Gerl, A Fossa, SD Beyer, J Pont, J Einhorn, L Kanz, L Bokemeyer, C
Citation: Jt. Hartmann et al., The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors, CANCER, 88(11), 2000, pp. 2629-2635

Authors: Hebart, H Loffler, J Reitze, H Engel, A Schumacher, U Klingebiel, T Bader, P Bohme, A Martin, H Bunjes, D Kern, WV Kanz, L Einsele, H
Citation: H. Hebart et al., Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia, BR J HAEM, 111(2), 2000, pp. 635-640

Authors: Mohle, R Schittenhelm, M Failenschmid, C Bautz, F Kratz-Albers, K Serve, H Brugger, W Kanz, L
Citation: R. Mohle et al., Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia, BR J HAEM, 110(3), 2000, pp. 563-572

Authors: Beck, R Neipel, F Canji, B Hebart, H Kanz, L Jahn, G Einsele, H
Citation: R. Beck et al., Absence of human herpesvirus 8 DNA sequences in leucapheresis products andbone marrow samples of patients with advanced multiple myeloma, BR J HAEM, 109(3), 2000, pp. 676-677
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>